Cardiovascular Diseases, Heart Disease Risk Factors
Conditions
Brief summary
This pilot study uses a state-of-the-science combination of remote behavioral monitoring, real-time experience sampling, in-lab physiological assessments, and extraction of neighborhood-level characteristics to (1) Examine the impact of daily experience (i.e., racial discrimination, affective states, stress) on health behaviors (i.e., physical activity, sedentary behavior, sleep) at the intrapersonal level among Black women; (2) Test the association between daily behaviors and impairments in biomarkers associated with vascular function/health (i.e., augmented systemic inflammation and oxidative stress, impaired peripheral/cerebral vascular function, increased large artery stiffness), as well as the impact of daily experience on the relationship between behaviors and vascular function; and (3) Explore the influence of neighborhood-level characteristics (i.e., social environment factors: i.e., neighborhood income and poverty, racial composition; and built environment context, such as park density and walkability) on daily experience and health behaviors.
Interventions
BEHAVIORALObservational Group
All participants will go through a series of lab-based assessments to evaluate their vascular health. These assessments include: heart rhythm/rate, blood pressure, large blood vessel flow, central aortic blood pressure and pulse wave velocity, brain blood flow, carbon dioxide concentration, flow mediated dilation/blood vessel responsiveness, breathing rate, and cerebral vasomotor reactivity. In addition, venous blood sample will be taken to identify biomarkers that are associated with elevating blood pressure and decreasing blood flow. The 10-day monitoring period includes a wrist-worn activity tracker and a blood pressure monitor bracelet; a smartphone app that will prompt surveys up to 6 times a day to assess behaviors, social/physical context, mood/stress, and experience of racial discrimination/microaggression. Participants will also collect saliva samples on three consecutive days during the 10-day monitoring period.
Sponsors
The University of Texas at Arlington
American Heart Association
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes
Inclusion criteria
* born and identified as female; * between 18-49 years old; * self-identify as Black or African American; * not currently pregnant; * ownership of a smartphone with Internet access; * able to speak and read English
Exclusion criteria
* diagnosed hypertension, cardiovascular, respiratory, metabolic, and/or neurological disorders; * functional limitations or health issues that preclude physical activity; * currently taking medications for thyroid function or psychological conditions such as depression, anxiety, and mood disorders; * current use of oral or inhalant corticosteroids for asthma; * have regularly smoked within the last 2 years.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Macrovascular function | Day 1 | Macrovascular function will be assessed as brachial artery vasodilation following a period of suprasystolic cuff occlusion. Microvascular function will be assessed as the % change in blood velocity from baseline following cuff release. |
| Arterial Stiffness | Day 1 | An appropriately sized blood pressure cuff will be placed on the upper arm and central (aortic) and peripheral (arm) blood pressure will be assessed using the non-invasive SphygmoCor Xcel device. This device provides measurement of augmentation index (in percentage), which is an indicator of arterial stiffness. |
| Blood Flow Measurements (Large Blood Vessels) | Day 1 | A Doppler ultrasound probe will be used to measure blood flow in the upper arm, leg, and/or neck (e.g., brachial artery, femoral artery, and carotid artery, respectively). |
| Blood Flow Measurements (Cerebral Blood Vessels) | Day 1 | Cerebral blood flow will be indexed from the velocity of blood flowing through the middle cerebral artery. This will be accomplished using transcranial Doppler ultrasound. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Physical activity | Day 2 to Day 11 | Daily physical activity level will be assessed via a wrist-worn accelerometer. |
Countries
United States
Outcome results
None listed